According to a recent article in The Guardian, “As soon as a vaccine is approved, it’s going to be needed in vast quantities. In a best-case scenario, mass manufacture probably won’t arrive before 2021 – and many of the organisations in the Covid-19 vaccine race simply don’t have the necessary production capacity.”

As the COVID-19 pandemic continues to take its toll across the globe, more and more companies are mandating that their employees work from home to ensure their safety and help flatten the curve.

Process automation is critical to any organization's growth in today's rapidly evolving world of business. To achieve their goals, many companies are turning to emerging technology for help, most notably artificial intelligence (AI), machine learning and robotics.

Faster and more accurate ways of doing business have always been a priority. Robotic Process Automation (RPA) can help reduce your costs while improving the quality of many repetitive, high-volume tasks.